Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-EN Version v2-EN
Language English English
Date Updated 2019-10-16 2019-08-21
Drug Identification Number 02189062 02189062
Brand name BREVICON 1/35 TABLETS (28-DAY PACK) BREVICON 1/35 TABLETS (28-DAY PACK)
Common or Proper name Brevicon Brevicon
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients ETHINYL ESTRADIOL NORETHINDRONE ETHINYL ESTRADIOL NORETHINDRONE
Strength(s) 0.035MG 1MG 0.035MG 1MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 28's 28's
ATC code G03AA G03AA
ATC description HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2019-09-13 2019-09-13
Actual start date 2019-09-09
Estimated end date 2019-10-15 2019-09-27
Actual end date 2019-10-15
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Other presentations available: Brevicon 1mg/0.035mg 21's day pack Other presentations available: Brevicon 1mg/0.035mg 21's day pack
Health Canada comments